QBFM
OMED

QS Batterymarch Financial Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

QS Batterymarch Financial Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.16M Sell
61,200
-5,600
-8% -$113K 0.03% 502
2014
Q2 		$1.56M Buy
+66,800
New +$1.65M 0.04% 467

Other funds holding OMED

SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Batterymarch Financial Management's OMED Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its OncoMed Pharmaceuticals, Inc. (OMED) stake by 8.4% in Q3 2014, selling an estimated $113K and leaving 61,200 shares worth $1.16M. The position accounts for 0.03% of the portfolio, ranked #502.

QS Batterymarch Financial Management first reported a position in OMED in Q2 2014 and has held it in 2 quarters since. The position peaked at $1.56M in Q2 2014. 62 funds tracked by Wall St. Rank hold OMED as of Q3 2014.

  • QS Batterymarch Financial Management held 61,200 shares of OncoMed Pharmaceuticals, Inc. worth $1.16M as of Q3 2014.
  • QS Batterymarch Financial Management sold 5,600 OncoMed Pharmaceuticals, Inc. shares in Q3 2014, an estimated $113K.
  • OncoMed Pharmaceuticals, Inc. made up 0.03% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #502 holding.
  • QS Batterymarch Financial Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2014 and has held it in 2 quarters since.
  • QS Batterymarch Financial Management's OncoMed Pharmaceuticals, Inc. position peaked at $1.56M in Q2 2014.
  • 62 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.